Optik Research Updates image presented by CRO

Myopia Control: Ortho-K vs. Low-Dose Atropine

Based on: JAMA Ophthalmology, 2025 – Randomized Clinical Trial At a Glance Population: Children & adolescents with progressing...

Read More
Fighting Blindness Canada research

Gene Editing Therapy to be Tested for Treatment of Wet AMD

A phase 1 clinical trial will be launching soon to test a gene editing approach for wet age-related macular degeneration (wet AMD) In wet AMD...

Read More
Fighting Blindness Canada research

FBC Funded Research Moves to Phase 2/3 Clinical Trial for Diabetic Macular Edema

An intact blood-retinal barrier, important for proper retinal function, is disrupted in eye diseases such as wet age-related macular degeneration...

Read More
Fighting Blindness Canada

New Gene Replacement Clinical Trial Launched for RP Test

ViGeneron in Munich, Germany has launched a new Phase 1b clinical trial testing a novel gene replacement therapy in individuals affected by...

Read More
Fighting Blindness Canada

Clinical Trial Results for New Treatments for AMD and DME

Anti-VEGF medications can prevent vision loss and even restore some vision for age-related macular degeneration (AMD) patients However, they require...

Read More